References
Davis LG, Dibner MD, Battey JF (1986) Preparation of DNA from eukaryotic cells: general method. InBasic Methods in Molecular Biology. New York: Elsevier, 44–46.
Goto Y, Nonaka I, Horai S (1990) A mutation in the tRNA-Leu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies.Nature 348: 651–653.
Holt IJ, Harding AE, Morgan-Hughes JA (1988) Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies.Nature 331: 717–719.
Holt IJ, Harding AE, Cooper JM et al (1989) Mitochondrial myopathies: clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA.Ann Neurol 26: 699–708.
Kobayashi Y, Momoi MY, Tominaga K et al (1990) A point mutation in the mitochondrial tRNA-Leu (UUR) gene in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and strokelike episodes).Biochem Biophys Res Commun 173: 816–822.
Kobayashi Y, Momoi MY, Tominaga K et al (1991) Respiration-deficient cells are caused by a single point mutation in the mitochondrial tRNA-Leu (UUR) gene in mitochondrial myopathy, encephalopathy, lactic acidosis and strokelike episodes (MELAS).Am J Hum Genet 49: 590–599.
Montagna P, Gallassi R, Medori R et al (1988) MELAS syndrome: characteristic migrainous and epileptic features and maternal transmission.Neurology 38: 751–754.
Moraes CT, DiMauro S, Zeviani et al (1989) Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome.N Engl J Med 320: 1293–1299.
Nakamigawa T, Momoi MY, Momoi T, Yanagisawa M (1988) Generation of human myogenic cell lines by the transformation of primary culture with origin-defective SV40 DNA.J Neurol Sci 83: 305–319.
Pavlakis SG, Phillips PC, DiMauro S, Devivo DC, Rowland LP (1984) Mitochondrial myopathy, encephalopathy, lactic acidosis and strokelike episodes: a distinctive clinical syndrome.Ann Neurol 16: 481–488.
Ponzetto C, Bresolin N, Bordoni A et al (1990) Kearns-Sayre syndrome: different amount of deleted mitochondrial DNA are present in several autopic tissues.J Neurol Sci 96: 207–210.
Saiki RK (1989) The design and optimization of the PCR. In Erlich HA, ed.PCR Technology: Principles and Applications for DNA Amplification. New York: Stickton, 7–16.
Shanske S, Moraes CT, Lombes A et al (1990) Widespread tissue distribution of mitochondrial DNA deletions in Kearns-Sayre syndrome.Neurology 40: 24–28.
Shimoizumi H, Momoi MY, Ohta S, Kagawa Y, Momoi T, Yanagisawa M (1989) Cytochromec oxidase-deficient myogenic cell lines in mitochondrial myopathy.Ann Neurol 25: 615–621.
Shoffner JM, Lott MT, Lezza AMS, Seibel P, Ballinger SW, Wallace DC (1990) Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA-Lys mutation.Cell 61: 931–937.
Yoneda M, Tanno Y, Horai S, Ozawa T, Miyatake T, Tsuji S (1990) A common mitochondrial DNA mutation in the tRNA-Lys of patients with myoclonus epilepsy associated with ragged-red fibers.Biochem Int 21: 789–796.
Zeviani M, Gellera C, Pannacci M et al (1990) Tissue distribution and transmission of mitochondrial DNA deletions in mitochondrial myopathies.Ann Neurol 28: 94–97.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kobayashi, Y., Ichihashi, K., Ohta, S. et al. The mutant mitochondrial genes in mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) were selectively amplified through generations. J Inherit Metab Dis 15, 803–808 (1992). https://doi.org/10.1007/BF01800025
Issue Date:
DOI: https://doi.org/10.1007/BF01800025